Hengrui Pharmaceutical announced that the company will hold its first extraordinary shareholders' meeting in 2026 on September 24, 2026 to consider matters including the proposed adoption of the 2026 H share plan. In order to determine the list of H share shareholders entitled to attend the shareholders' meeting, the company will suspend H share transfer registration from September 21 to September 24, 2026. There will be no H share transfer registration procedures during this period. The record date is September 24, 2026. H share shareholders who wish to attend and vote must submit the transfer documents and related shares to the H share transfer registration office before 4:30 p.m. on September 18, 2026 to complete registration.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.